Nifurzide

This classification denotes an anti-infective agent with the molecular formula C12H8N4O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) Z35R6K4C26, chemically known as 2-thiophenecarboxylic acid, 5-nitro-, (3-(5-nitro-2-furanyl)-2-propenylidene)hydrazide but more generally known as nifurzide, which bears US NIH Compound Identifier 9571044. European Medicines Agency schedules Nifurzide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09283MIG. The term NIFURZIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules nifurzide in its Anatomical Therapeutic Chemical (ATC) Classification. NIFURZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule nifurzide under HS 29349990 and SITC 51579. As of Q4 2014, NIFURZIDE remains US FDA's Preferred Term for this commodity. Nifurzide bears US NLM identifiers UMLS ID C0068746 and NCI Concept Code C90985. SMILES: S1C(CCC1[N](=O)O)C(=O)N/N=C/C=C/C1OC([N](=O)O)CC1.